Click for best price
Nonvalvular Atrial Fibrillation Drugs Market Size, Share 2023
The global Nonvalvular Atrial Fibrillation Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Atrial fibrillation, or A-fib, refers to an erratic heart rhythm. This can result from leaky or blocked valves in the heart. However, the valves are not always involved. In this case, the diagnosis is nonvalvular A-fib.
This report aims to provide a comprehensive presentation of the global market for Nonvalvular Atrial Fibrillation Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonvalvular Atrial Fibrillation Drugs. This report contains market size and forecasts of Nonvalvular Atrial Fibrillation Drugs in global, including the following market information:
- Global Nonvalvular Atrial Fibrillation Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Warfarin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nonvalvular Atrial Fibrillation Drugs include Amneal Pharma, Cipla (InvaGen), Orion Corporation, Bristol Myers Squibb, UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd), Taro Pharmaceutical Industries Ltd., CTX Life Sciences, Mehta API Pvt and Amtec Health Care Pvt, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nonvalvular Atrial Fibrillation Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nonvalvular Atrial Fibrillation Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Nonvalvular Atrial Fibrillation Drugs Market Segment Percentages, by Type, 2022 (%)
- Warfarin
- Dabigatran Etexilate Mesylate
- Xarelto
- Apixaban
Global Nonvalvular Atrial Fibrillation Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Nonvalvular Atrial Fibrillation Drugs Market Segment Percentages, by Application, 2022 (%)
Global Nonvalvular Atrial Fibrillation Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Nonvalvular Atrial Fibrillation Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Nonvalvular Atrial Fibrillation Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Nonvalvular Atrial Fibrillation Drugs revenues share in global market, 2022 (%)
Key players include:
- Amneal Pharma
- Cipla (InvaGen)
- Orion Corporation
- Bristol Myers Squibb
- UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd)
- Taro Pharmaceutical Industries Ltd.
- CTX Life Sciences
- Mehta API Pvt
- Amtec Health Care Pvt
- Polpharma
- Apotex Pharmachem
- Dr. Reddy?s
- Jubilant Pharma
- Vasudha Pharma Chem
- Tapi Teva
- Metrochem
- Lee Pharma
- Qilu Pharmaceutical
- Shanghai Pharmaceutical Group
- Henan Zhongjie Pharmaceutical
- Tianyu Pharm
- Jinan Jianfeng Chemical
- Hisun
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nonvalvular Atrial Fibrillation Drugs, market overview.
Chapter 2: Global Nonvalvular Atrial Fibrillation Drugs market size in revenue.
Chapter 3: Detailed analysis of Nonvalvular Atrial Fibrillation Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nonvalvular Atrial Fibrillation Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Nonvalvular Atrial Fibrillation Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
119 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nonvalvular Atrial Fibrillation Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nonvalvular Atrial Fibrillation Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nonvalvular Atrial Fibrillation Drugs Overall Market Size
2.1 Global Nonvalvular Atrial Fibrillation Drugs Market Size: 2022 VS 2030
2.2 Global Nonvalvular Atrial Fibrillation Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nonvalvular Atrial Fibrillation Drugs Players in Global Market
3.2 Top Global Nonvalvular Atrial Fibrillation Drugs Companies Ranked by Revenue
3.3 Global Nonvalvular Atrial Fibrillation Drugs Revenue by Companies
3.4 Top 3 and Top 5 Nonvalvular Atrial Fibrillation Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nonvalvular Atrial Fibrillation Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nonvalvular Atrial Fibrillation Drugs Players in Global Market
3.6.1 List of Global Tier 1 Nonvalvular Atrial Fibrillation Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Nonvalvular Atrial Fibrillation Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nonvalvular Atrial Fibrillation Drugs Market Size Markets, 2022 & 2030
4.1.2 Warfarin
4.1.3 Dabigatran Etexilate Mesylate
4.1.4 Xarelto
4.1.5 Apixaban
4.2 By Type - Global Nonvalvular Atrial Fibrillation Drugs Revenue & Forecasts
4.2.1 By Type - Global Nonvalvular Atrial Fibrillation Drugs Revenue, 2018-2023
4.2.2 By Type - Global Nonvalvular Atrial Fibrillation Drugs Revenue, 2024-2030
4.2.3 By Type - Global Nonvalvular Atrial Fibrillation Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nonvalvular Atrial Fibrillation Drugs Market Size, 2022 & 2030
5.1.2 ????
5.1.3 ????
5.1.4 ????
5.2 By Application - Global Nonvalvular Atrial Fibrillation Drugs Revenue & Forecasts
5.2.1 By Application - Global Nonvalvular Atrial Fibrillation Drugs Revenue, 2018-2023
5.2.2 By Application - Global Nonvalvular Atrial Fibrillation Drugs Revenue, 2024-2030
5.2.3 By Application - Global Nonvalvular Atrial Fibrillation Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Nonvalvular Atrial Fibrillation Drugs Market Size, 2022 & 2030
6.2 By Region - Global Nonvalvular Atrial Fibrillation Drugs Revenue & Forecasts
6.2.1 By Region - Global Nonvalvular Atrial Fibrillation Drugs Revenue, 2018-2023
6.2.2 By Region - Global Nonvalvular Atrial Fibrillation Drugs Revenue, 2024-2030
6.2.3 By Region - Global Nonvalvular Atrial Fibrillation Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Nonvalvular Atrial Fibrillation Drugs Revenue, 2018-2030
6.3.2 US Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.3.3 Canada Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.3.4 Mexico Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Nonvalvular Atrial Fibrillation Drugs Revenue, 2018-2030
6.4.2 Germany Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.4.3 France Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.4.4 U.K. Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.4.5 Italy Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.4.6 Russia Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.4.8 Benelux Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Nonvalvular Atrial Fibrillation Drugs Revenue, 2018-2030
6.5.2 China Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.5.3 Japan Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.5.4 South Korea Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.5.6 India Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Nonvalvular Atrial Fibrillation Drugs Revenue, 2018-2030
6.6.2 Brazil Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.6.3 Argentina Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nonvalvular Atrial Fibrillation Drugs Revenue, 2018-2030
6.7.2 Turkey Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.7.3 Israel Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
6.7.5 UAE Nonvalvular Atrial Fibrillation Drugs Market Size, 2018-2030
7 Nonvalvular Atrial Fibrillation Drugs Companies Profiles
7.1 Amneal Pharma
7.1.1 Amneal Pharma Company Summary
7.1.2 Amneal Pharma Business Overview
7.1.3 Amneal Pharma Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.1.4 Amneal Pharma Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.1.5 Amneal Pharma Key News & Latest Developments
7.2 Cipla (InvaGen)
7.2.1 Cipla (InvaGen) Company Summary
7.2.2 Cipla (InvaGen) Business Overview
7.2.3 Cipla (InvaGen) Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.2.4 Cipla (InvaGen) Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.2.5 Cipla (InvaGen) Key News & Latest Developments
7.3 Orion Corporation
7.3.1 Orion Corporation Company Summary
7.3.2 Orion Corporation Business Overview
7.3.3 Orion Corporation Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.3.4 Orion Corporation Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.3.5 Orion Corporation Key News & Latest Developments
7.4 Bristol Myers Squibb
7.4.1 Bristol Myers Squibb Company Summary
7.4.2 Bristol Myers Squibb Business Overview
7.4.3 Bristol Myers Squibb Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.4.4 Bristol Myers Squibb Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.4.5 Bristol Myers Squibb Key News & Latest Developments
7.5 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd)
7.5.1 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Company Summary
7.5.2 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Business Overview
7.5.3 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.5.4 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.5.5 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Key News & Latest Developments
7.6 Taro Pharmaceutical Industries Ltd.
7.6.1 Taro Pharmaceutical Industries Ltd. Company Summary
7.6.2 Taro Pharmaceutical Industries Ltd. Business Overview
7.6.3 Taro Pharmaceutical Industries Ltd. Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.6.4 Taro Pharmaceutical Industries Ltd. Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.6.5 Taro Pharmaceutical Industries Ltd. Key News & Latest Developments
7.7 CTX Life Sciences
7.7.1 CTX Life Sciences Company Summary
7.7.2 CTX Life Sciences Business Overview
7.7.3 CTX Life Sciences Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.7.4 CTX Life Sciences Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.7.5 CTX Life Sciences Key News & Latest Developments
7.8 Mehta API Pvt
7.8.1 Mehta API Pvt Company Summary
7.8.2 Mehta API Pvt Business Overview
7.8.3 Mehta API Pvt Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.8.4 Mehta API Pvt Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.8.5 Mehta API Pvt Key News & Latest Developments
7.9 Amtec Health Care Pvt
7.9.1 Amtec Health Care Pvt Company Summary
7.9.2 Amtec Health Care Pvt Business Overview
7.9.3 Amtec Health Care Pvt Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.9.4 Amtec Health Care Pvt Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.9.5 Amtec Health Care Pvt Key News & Latest Developments
7.10 Polpharma
7.10.1 Polpharma Company Summary
7.10.2 Polpharma Business Overview
7.10.3 Polpharma Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.10.4 Polpharma Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.10.5 Polpharma Key News & Latest Developments
7.11 Apotex Pharmachem
7.11.1 Apotex Pharmachem Company Summary
7.11.2 Apotex Pharmachem Business Overview
7.11.3 Apotex Pharmachem Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.11.4 Apotex Pharmachem Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.11.5 Apotex Pharmachem Key News & Latest Developments
7.12 Dr. Reddy?s
7.12.1 Dr. Reddy?s Company Summary
7.12.2 Dr. Reddy?s Business Overview
7.12.3 Dr. Reddy?s Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.12.4 Dr. Reddy?s Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.12.5 Dr. Reddy?s Key News & Latest Developments
7.13 Jubilant Pharma
7.13.1 Jubilant Pharma Company Summary
7.13.2 Jubilant Pharma Business Overview
7.13.3 Jubilant Pharma Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.13.4 Jubilant Pharma Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.13.5 Jubilant Pharma Key News & Latest Developments
7.14 Vasudha Pharma Chem
7.14.1 Vasudha Pharma Chem Company Summary
7.14.2 Vasudha Pharma Chem Business Overview
7.14.3 Vasudha Pharma Chem Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.14.4 Vasudha Pharma Chem Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.14.5 Vasudha Pharma Chem Key News & Latest Developments
7.15 Tapi Teva
7.15.1 Tapi Teva Company Summary
7.15.2 Tapi Teva Business Overview
7.15.3 Tapi Teva Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.15.4 Tapi Teva Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.15.5 Tapi Teva Key News & Latest Developments
7.16 Metrochem
7.16.1 Metrochem Company Summary
7.16.2 Metrochem Business Overview
7.16.3 Metrochem Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.16.4 Metrochem Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.16.5 Metrochem Key News & Latest Developments
7.17 Lee Pharma
7.17.1 Lee Pharma Company Summary
7.17.2 Lee Pharma Business Overview
7.17.3 Lee Pharma Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.17.4 Lee Pharma Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.17.5 Lee Pharma Key News & Latest Developments
7.18 Qilu Pharmaceutical
7.18.1 Qilu Pharmaceutical Company Summary
7.18.2 Qilu Pharmaceutical Business Overview
7.18.3 Qilu Pharmaceutical Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.18.4 Qilu Pharmaceutical Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.18.5 Qilu Pharmaceutical Key News & Latest Developments
7.19 Shanghai Pharmaceutical Group
7.19.1 Shanghai Pharmaceutical Group Company Summary
7.19.2 Shanghai Pharmaceutical Group Business Overview
7.19.3 Shanghai Pharmaceutical Group Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.19.4 Shanghai Pharmaceutical Group Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.19.5 Shanghai Pharmaceutical Group Key News & Latest Developments
7.20 Henan Zhongjie Pharmaceutical
7.20.1 Henan Zhongjie Pharmaceutical Company Summary
7.20.2 Henan Zhongjie Pharmaceutical Business Overview
7.20.3 Henan Zhongjie Pharmaceutical Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.20.4 Henan Zhongjie Pharmaceutical Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.20.5 Henan Zhongjie Pharmaceutical Key News & Latest Developments
7.21 Tianyu Pharm
7.21.1 Tianyu Pharm Company Summary
7.21.2 Tianyu Pharm Business Overview
7.21.3 Tianyu Pharm Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.21.4 Tianyu Pharm Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.21.5 Tianyu Pharm Key News & Latest Developments
7.22 Jinan Jianfeng Chemical
7.22.1 Jinan Jianfeng Chemical Company Summary
7.22.2 Jinan Jianfeng Chemical Business Overview
7.22.3 Jinan Jianfeng Chemical Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.22.4 Jinan Jianfeng Chemical Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.22.5 Jinan Jianfeng Chemical Key News & Latest Developments
7.23 Hisun
7.23.1 Hisun Company Summary
7.23.2 Hisun Business Overview
7.23.3 Hisun Nonvalvular Atrial Fibrillation Drugs Major Product Offerings
7.23.4 Hisun Nonvalvular Atrial Fibrillation Drugs Revenue in Global Market (2018-2023)
7.23.5 Hisun Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nonvalvular Atrial Fibrillation Drugs Market Opportunities & Trends in Global Market
Table 2. Nonvalvular Atrial Fibrillation Drugs Market Drivers in Global Market
Table 3. Nonvalvular Atrial Fibrillation Drugs Market Restraints in Global Market
Table 4. Key Players of Nonvalvular Atrial Fibrillation Drugs in Global Market
Table 5. Top Nonvalvular Atrial Fibrillation Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Nonvalvular Atrial Fibrillation Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Nonvalvular Atrial Fibrillation Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Nonvalvular Atrial Fibrillation Drugs Product Type
Table 9. List of Global Tier 1 Nonvalvular Atrial Fibrillation Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nonvalvular Atrial Fibrillation Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Nonvalvular Atrial Fibrillation Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Nonvalvular Atrial Fibrillation Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Nonvalvular Atrial Fibrillation Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Nonvalvular Atrial Fibrillation Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Amneal Pharma Company Summary
Table 31. Amneal Pharma Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 32. Amneal Pharma Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Amneal Pharma Key News & Latest Developments
Table 34. Cipla (InvaGen) Company Summary
Table 35. Cipla (InvaGen) Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 36. Cipla (InvaGen) Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Cipla (InvaGen) Key News & Latest Developments
Table 38. Orion Corporation Company Summary
Table 39. Orion Corporation Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 40. Orion Corporation Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Orion Corporation Key News & Latest Developments
Table 42. Bristol Myers Squibb Company Summary
Table 43. Bristol Myers Squibb Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 44. Bristol Myers Squibb Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol Myers Squibb Key News & Latest Developments
Table 46. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Company Summary
Table 47. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 48. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Key News & Latest Developments
Table 50. Taro Pharmaceutical Industries Ltd. Company Summary
Table 51. Taro Pharmaceutical Industries Ltd. Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 52. Taro Pharmaceutical Industries Ltd. Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Taro Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 54. CTX Life Sciences Company Summary
Table 55. CTX Life Sciences Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 56. CTX Life Sciences Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. CTX Life Sciences Key News & Latest Developments
Table 58. Mehta API Pvt Company Summary
Table 59. Mehta API Pvt Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 60. Mehta API Pvt Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Mehta API Pvt Key News & Latest Developments
Table 62. Amtec Health Care Pvt Company Summary
Table 63. Amtec Health Care Pvt Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 64. Amtec Health Care Pvt Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Amtec Health Care Pvt Key News & Latest Developments
Table 66. Polpharma Company Summary
Table 67. Polpharma Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 68. Polpharma Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Polpharma Key News & Latest Developments
Table 70. Apotex Pharmachem Company Summary
Table 71. Apotex Pharmachem Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 72. Apotex Pharmachem Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Apotex Pharmachem Key News & Latest Developments
Table 74. Dr. Reddy?s Company Summary
Table 75. Dr. Reddy?s Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 76. Dr. Reddy?s Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Dr. Reddy?s Key News & Latest Developments
Table 78. Jubilant Pharma Company Summary
Table 79. Jubilant Pharma Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 80. Jubilant Pharma Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Jubilant Pharma Key News & Latest Developments
Table 82. Vasudha Pharma Chem Company Summary
Table 83. Vasudha Pharma Chem Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 84. Vasudha Pharma Chem Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Vasudha Pharma Chem Key News & Latest Developments
Table 86. Tapi Teva Company Summary
Table 87. Tapi Teva Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 88. Tapi Teva Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Tapi Teva Key News & Latest Developments
Table 90. Metrochem Company Summary
Table 91. Metrochem Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 92. Metrochem Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Metrochem Key News & Latest Developments
Table 94. Lee Pharma Company Summary
Table 95. Lee Pharma Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 96. Lee Pharma Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. Lee Pharma Key News & Latest Developments
Table 98. Qilu Pharmaceutical Company Summary
Table 99. Qilu Pharmaceutical Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 100. Qilu Pharmaceutical Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 101. Qilu Pharmaceutical Key News & Latest Developments
Table 102. Shanghai Pharmaceutical Group Company Summary
Table 103. Shanghai Pharmaceutical Group Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 104. Shanghai Pharmaceutical Group Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 105. Shanghai Pharmaceutical Group Key News & Latest Developments
Table 106. Henan Zhongjie Pharmaceutical Company Summary
Table 107. Henan Zhongjie Pharmaceutical Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 108. Henan Zhongjie Pharmaceutical Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 109. Henan Zhongjie Pharmaceutical Key News & Latest Developments
Table 110. Tianyu Pharm Company Summary
Table 111. Tianyu Pharm Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 112. Tianyu Pharm Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 113. Tianyu Pharm Key News & Latest Developments
Table 114. Jinan Jianfeng Chemical Company Summary
Table 115. Jinan Jianfeng Chemical Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 116. Jinan Jianfeng Chemical Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 117. Jinan Jianfeng Chemical Key News & Latest Developments
Table 118. Hisun Company Summary
Table 119. Hisun Nonvalvular Atrial Fibrillation Drugs Product Offerings
Table 120. Hisun Nonvalvular Atrial Fibrillation Drugs Revenue (US$, Mn) & (2018-2023)
Table 121. Hisun Key News & Latest Developments
List of Figures
Figure 1. Nonvalvular Atrial Fibrillation Drugs Segment by Type in 2022
Figure 2. Nonvalvular Atrial Fibrillation Drugs Segment by Application in 2022
Figure 3. Global Nonvalvular Atrial Fibrillation Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nonvalvular Atrial Fibrillation Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Nonvalvular Atrial Fibrillation Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nonvalvular Atrial Fibrillation Drugs Revenue in 2022
Figure 8. By Type - Global Nonvalvular Atrial Fibrillation Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Nonvalvular Atrial Fibrillation Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Nonvalvular Atrial Fibrillation Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Nonvalvular Atrial Fibrillation Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Nonvalvular Atrial Fibrillation Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Nonvalvular Atrial Fibrillation Drugs Revenue Market Share, 2018-2030
Figure 16. US Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Nonvalvular Atrial Fibrillation Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Nonvalvular Atrial Fibrillation Drugs Revenue Market Share, 2018-2030
Figure 28. China Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Nonvalvular Atrial Fibrillation Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Nonvalvular Atrial Fibrillation Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Nonvalvular Atrial Fibrillation Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Amneal Pharma Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Cipla (InvaGen) Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Orion Corporation Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol Myers Squibb Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Taro Pharmaceutical Industries Ltd. Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. CTX Life Sciences Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Mehta API Pvt Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Amtec Health Care Pvt Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Polpharma Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Apotex Pharmachem Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Dr. Reddy?s Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Jubilant Pharma Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Vasudha Pharma Chem Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Tapi Teva Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Metrochem Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Lee Pharma Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Qilu Pharmaceutical Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Shanghai Pharmaceutical Group Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Henan Zhongjie Pharmaceutical Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Tianyu Pharm Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Jinan Jianfeng Chemical Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Hisun Nonvalvular Atrial Fibrillation Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
